Palantir Drops as Slowing Contracts Drag Strong Results

Key Moments

Palantir Technologies (NYSE:PLTR) is falling 6.0% in pre-market trade to $167.66, extending a post-earnings selloff.
Q3 2026 revenue rose 96% year-over-year to $2.31 billion, topping the roughly $2.18 billion consensus, with adjusted EPS of $0.44 versus $0.41 expected.
Total contract value growth slowed sharply to 6% year-over-year, down from 49% in Q2, with U.S. commercial TCV growth dropping to 11% from 153%.

Earnings Beat Fails to Support Share Price

Palantir Technologies stock is under pressure in pre-open trading, sliding 6.0% to $167.66. The move continues an after-hours decline that began Monday evening after the company released its Q3 2026 earnings.

The company reported revenue of $2.31 billion, a 96% year-over-year increase and above the roughly $2.18 billion consensus estimate. Adjusted EPS came in at $0.44, exceeding expectations of $0.41. Despite these headline beats, investors focused on weaker signals within the company’s bookings, triggering a negative reaction in the stock.

Sharp Slowdown in Contract Momentum

The primary issue driving the selloff is a marked slowdown in contract growth. Total contract value for the quarter was $2.918 billion, up 6% year-over-year, a substantial deceleration compared with the 49% growth posted in Q2.

The moderation was especially pronounced in U.S. commercial activity. U.S. commercial TCV, which had surged 153% year-over-year in Q2, expanded just 11% in Q3.

Analysts highlighted that the widening gap between robust reported revenue and cooling new deal activity raises concerns about the durability of the company’s growth trajectory and the strength of the pipeline supporting 2027 performance.

Metric	Q3 2026	Comparison / Context
Pre-market share price move	-6.0% to $167.66	Extends post-earnings after-hours decline
Revenue	$2.31 billion	Up 96% year-over-year; above roughly $2.18 billion consensus
Adjusted EPS	$0.44	Ahead of $0.41 expected
Total contract value (TCV)	$2.918 billion	Up 6% year-over-year vs. 49% in Q2
U.S. commercial TCV growth	11% year-over-year	Down from 153% year-over-year in Q2
Insider selling (prior 90 days)	Over $97 million	Amid trailing P/E above 150 times earnings

Analyst Actions and Valuation Concerns

Analyst commentary added to the cautious tone. Morgan Stanley lifted its price target on Palantir to $233 but maintained an Equalweight rating, signaling a more balanced risk-reward view despite the target hike.

Separately, at least one prominent analyst cut the stock to Hold on November 3, stating that the valuation remains elevated even after the post-earnings pullback and that the current level does not offer a comfortable margin of safety.

Market Context and Sector Backdrop

Broader market moves did not provide an obvious macro explanation for the decline. The NASDAQ edged slightly higher, while the S&P 500 was effectively unchanged, suggesting that the weakness in Palantir is driven by company-specific factors rather than broad market stress.

The article noted that the AI and software universe has been under valuation scrutiny, with Palantir’s peers in the Software & IT Services group also facing selling pressure in the prior session.

Insider Selling and Elevated Multiples

Investor sensitivity to valuation is being reinforced by notable insider activity. Insiders have sold over $97 million in stock over the prior 90 days, which has become another point of caution for shareholders assessing risk at a trailing P/E above 150 times earnings.

Investor Takeaways

Overall, Palantir’s pre-market decline reflects a market reassessment of the balance between current performance and future growth visibility. While the company delivered substantial revenue growth and an upside earnings surprise, investors appeared unwilling to overlook the slowdown in total contract value and U.S. commercial deal momentum.

The reaction suggests that at current valuation levels, outperformance on revenue alone is no longer sufficient – investors also want confirmation that forward-looking bookings are expanding at a pace consistent with the company’s elevated multiples.